On ECHEMI
Home > Drugs > Selegiline Hydrochloride Capsules

Selegiline Hydrochloride Capsules

Function and Efficacy

Not yet clear.

Ingredients

The main ingredient of this product is selegiline hydrochloride, chemical name: (R)-N, @-dimethyl-N-(2-propyl)phenylethylamine hydrochloride.

Name Description Content CAS NO. Manufacturer
Selegiline hydrochlorideIngredients

Not yet clear

More
14611-52-0 18

Appearance

It is a hard capsule, and the contents are white or off-white granules and powder.

Indication

It can be used alone to treat early Parkinson's disease or in combination with levodopa or with levodopa and a peripheral dopa decarboxylase inhibitor; the combination of sinocycline and levodopa is particularly suitable for the treatment of motor fluctuations such as end-of-dose fluctuations caused by high-dose levodopa therapy.

Usage and Dosage

Oral. The starting dose is 5 mg (one tablet) in the morning. The dose of selegiline hydrochloride tablets can be increased to 10 mg (2 tablets) per day (taken once in the morning or divided into two doses in the morning and afternoon). If the patient shows adverse reactions similar to levodopa when taking levodopa preparations, the levodopa dose should be reduced. Or follow the doctor's advice.

Adverse Reactions

Selegiline hydrochloride is well tolerated when taken alone. There have been reports of dry mouth, transient elevations in serum aminotransferase values, and sleep disturbances (e.g., insomnia) in patients taking selegiline hydrochloride compared with placebo. Because selegiline hydrochloride can increase the effects of levodopa, adverse reactions to levodopa may also increase. When selegiline hydrochloride is added to patients already taking the maximum tolerated dose of levodopa, involuntary movements, nausea, agitation, confusion, hallucinations, headache, orthostatic hypotension, and dizziness may occur. Dysuria and rash have also been reported. Potential adverse reactions should be monitored. Therefore, the levodopa dose should be reduced by an average of 30 percent when selegiline hydrochloride is added to therapy.

Precautions

1. Those who are allergic to any component of Sijining are prohibited from using this product. 2. Pregnant and lactating women should not use this product.

Special Population Medication

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not suitable for pregnant and lactating women. Precautions for the elderly: See (Usage and Dosage).

Drug Interactions

Not yet clear.

Storage

seal.

Packaging Specification

5mg

Validity Period

24 months

Manufacturer

Anhui Biochem Bio-Pharmaceutical Co., Ltd.

  • Founded in:

    2003-12-17
  • Address:

    No. 30 Hongfeng Road, High-tech Development Zone, Hefei City, Anhui Province
  • Tax NO.:

    91340100752990430A
  • Registered Funds:

    70 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.